Premium
Tocilizumab administration in patients with SARS‐CoV‐2 infection: Subcutaneous injection vs intravenous infusion
Author(s) -
Shabani Minoosh,
Shokouhi Shervin,
Moradi Omid,
Saffaei Ali,
Sahraei Zahra
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26124
Subject(s) - tocilizumab , medicine , cytokine release syndrome , subcutaneous injection , cytokine storm , pharmacokinetics , interquartile range , route of administration , pharmacology , covid-19 , rheumatoid arthritis , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom